<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alexander, Lori</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Ponte, Charles D.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Risk of Drug-Induced Dysglycemia Typically Outweighed by Benefits</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">25-27</style></pages><abstract><style  face="normal" font="default" size="100%">A wide variety of drugs can “tip the balance of glucose homeostasis,” leading to dysglycemia. But, the risks and benefits of these drugs should be carefully considered, as their benefits may outweigh an increased risk of diabetes. This article discusses thiazide-induced dysglycemia, the association of statins with new-onset diabetes, the relationship between diabetes and mental illness, and strategies to prevent drug-induced dysglycemia.</style></abstract><number><style face="normal" font="default" size="100%">8</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>